advertisement
Singh K 20
Showing records 1 to 20 |
Display all abstracts from Singh K117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudySun MT
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorSamuelson TW
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
118001 Factors affecting adherence to glaucoma medication: Patient perspective from North IndiaSingh K; Singh A
Indian Journal of Ophthalmology 2024; 72: 391-396
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorDe Francesco T
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyCotton RM
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorAhmed IIK
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
118001 Factors affecting adherence to glaucoma medication: Patient perspective from North IndiaJain D
Indian Journal of Ophthalmology 2024; 72: 391-396
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyCharoenkijkajorn C
Ophthalmology science 2024; 4: 100448
118001 Factors affecting adherence to glaucoma medication: Patient perspective from North IndiaVerma V
Indian Journal of Ophthalmology 2024; 72: 391-396
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorGedde SJ
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyGarcia-Sanchez J
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorParanjpe VR
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyDalal R
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorSingh K
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyXia X; Lin JH
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorBrubaker JW; Grover DS
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudySingh K; Goldberg JL
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorFellman RL; Zhang AD
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot StudyLiu WW
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorBarton K
Journal of Cataract and Refractive Surgery 2024; 50: 97-103